PATIENT REPORTED OUTCOMES-CORE SHARED RESOURCE The Patient Reported Outcomes-Core Shared Resource (PRO-core) was developed in response to a growing number of cancer center investigators who require methodological consulting related to survey development, use, and analysis, as well as use of a customizable electronic data capture tool for collecting information directly from patients and other stakeholders. PRO Core provides a software platform and scientific consultation to investigators conducting PRO research. This includes clinical trials of new drugs, interventions with symptom and quality of life endpoints, and studies of the integration of PRO assessment into clinical care. Dr. Bennett is the faculty director and an Associate Professor of Health Policy and Management. She contributed as an investigator to the development and validation of the NCI Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). In fiscal year 2019, the SR was used by 27 faculty, 67% of whom were LCCC members. Importantly, the SR supports highly sophisticated methodology and is a national leader in Patient Reported Outcomes. These skills and methods allow the SR to support external cancer collaborators at multi-site trial locations such as Duke Cancer Institute, Emory University, Georgetown, and Moffit. PRO is requesting $111,249 for this SR which is approximately 39% of its fiscal year 2020 Operating budget. PRO Core has been a successful SR as demonstrated by the following metrics. PRO Core studies are supported by 11 NIH grants (5 from NCI, including 1 K award) and 3 Patient-Centered Outcomes Research Institute (PCORI) contracts. Studies are also supported by Genentech, the Breast Cancer Research Foundation, and pilot awards from the Alliance for Clinical Trials in Oncology cooperative group. PRO Core is supporting a growing portfolio of: 1) studies evaluating the implementation of PRO assessment in oncology care, and 2) studies collecting both PRO data and wearable / activity tracker (e.g. Garmin, Fitbit) data. PRO Core has developed technical capability and expertise in these areas, and the LCCC is now known for substantial scientific leadership in these two areas. In addition, PRO Core is supporting studies that evaluate the comparative effectiveness of new treatments and a new registry that tracks opioid need and use among post-operative patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089834
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Hu, Jiemiao; Sun, Chuang; Bernatchez, Chantale et al. (2018) T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors. Clin Cancer Res 24:2920-2934
DeKroon, Robert M; Gunawardena, Harsha P; Edwards, Rachel et al. (2018) Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A. MBio 9:
Bailey, Rachel M; Armao, Diane; Nagabhushan Kalburgi, Sahana et al. (2018) Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy. Mol Ther Methods Clin Dev 9:160-171
Liu, E; Tong, Y; Dotti, G et al. (2018) Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity. Leukemia 32:520-531
Chao, Yvonne L; Pecot, Chad V (2018) Immunotherapy combinations emerging in non-small-cell lung cancer. Immunotherapy 10:627-629
Braithwaite, Dejana; Miglioretti, Diana L; Zhu, Weiwei et al. (2018) Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort. JAMA Intern Med 178:494-501
Spencer, Jennifer C; Brewer, Noel T; Trogdon, Justin G et al. (2018) Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients. Am J Public Health 108:946-950
Smith, Collin-Jamal; Allard, Denise E; Wang, Yan et al. (2018) IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration. J Immunol 200:1580-1592
Montgomery, Nathan D; Tomoka, Tamiwe; Krysiak, Robert et al. (2018) Practical Successes in Telepathology Experiences in Africa. Clin Lab Med 38:141-150
Porrello, Alessandro; Leslie, Patrick L; Harrison, Emily B et al. (2018) Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking. Nat Commun 9:1988

Showing the most recent 10 out of 1525 publications